相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The relevance of miRNAs as promising biomarkers in lip cancer
Agnes Assao et al.
CLINICAL ORAL INVESTIGATIONS (2021)
Upregulation of miR-345-5p suppresses cell growth of lung adenocarcinoma by regulating ras homolog family member A (RhoA) and Rho/Rho associated protein kinase (Rho/ROCK) pathway
Qiao-Yun Zhou et al.
CHINESE MEDICAL JOURNAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
Marwa Elsayed et al.
BIOMEDICINES (2021)
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
Panagiotis Sarantis et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
Kentaro Gokita et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
Winston Wong et al.
CANCER MANAGEMENT AND RESEARCH (2020)
MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma
Jing Wu et al.
ARCHIVES OF ORAL BIOLOGY (2020)
Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8
Jingwei Cao et al.
CANCER CELL INTERNATIONAL (2020)
MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases
Ilya Ulasov et al.
CANCER LETTERS (2020)
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
Deciphering the Role of Innate Immune NF-kB Pathway in Pancreatic Cancer
Namrata Khurana et al.
CANCERS (2020)
Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management
Valerie Jentzsch et al.
CANCERS (2020)
MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8
Tinggang Mou et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Trans-3,5,4′ -trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498
Min Lu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene
Yan Yan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Jihye Yoo et al.
CANCERS (2019)
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
Afra Z. Daoud et al.
BMC CANCER (2019)
MicroRNA delivery through nanoparticles
Sharon Wei Ling Lee et al.
JOURNAL OF CONTROLLED RELEASE (2019)
miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
Anteneh A. Tesfaye et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
miR-345-5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2
Xiaoyang Ying et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer
Metin Uz et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Effects of miR-101, miR-345 on HBV replication regulation and on the growth of liver cancer cells
Aikun Ding et al.
ONCOLOGY LETTERS (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Pancreatic cancer 'mismatch' in Lynch syndrome
Andrew E. Hendifar et al.
BMJ OPEN GASTROENTEROLOGY (2019)
Polyamino Acid Layer-by-Layer (LbL) Constructed Silica-Supported Mesoporous Titania Nanocarriers for Stimuli-Responsive Delivery of microRNA 708 and Paclitaxel for Combined Chemotherapy
Biki Gupta et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
Lauren Herschbein et al.
BLOOD REVIEWS (2018)
A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma
Davide B. Gissi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
Functional roles and potential clinical application of miRNA-345-5p in prostate cancer
Ilker Tinay et al.
PROSTATE (2018)
Functional miRNAs in breast cancer drug resistance
Weizi Hu et al.
ONCOTARGETS AND THERAPY (2018)
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
Virender Kumar et al.
THERANOSTICS (2018)
Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
Hao Wang et al.
CLINICAL EPIGENETICS (2018)
mTOR signaling-related MicroRNAs and Cancer involvement
Ping Wang et al.
JOURNAL OF CANCER (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
Carol Cremin et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2018)
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma
Daoxiang Zhang et al.
CLINICAL CANCER RESEARCH (2017)
Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia
Yoko Tabe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Aleksandra Adamska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma
Miao Yu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1
Hui Zhang et al.
ONCOLOGY REPORTS (2017)
MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1
Aiwen Feng et al.
ONCOLOGY REPORTS (2017)
Functional expression of CCL8 and its interaction with chemokine receptor CCR3
Baosheng Ge et al.
BMC IMMUNOLOGY (2017)
Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy
Yaqing Li et al.
CANCER SCIENCE (2017)
MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer
Qi-guang Chen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
More deaths from pancreatic cancer than breast cancer in the EU by 2017
J. Ferlay et al.
ACTA ONCOLOGICA (2016)
Forkhead box Q1: A key player in the pathogenesis of tumors
Yang Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
Lishan Wang et al.
ONCOTARGET (2016)
Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
Jing Yu et al.
ONCOTARGET (2016)
Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives
Chao Yang et al.
ONCOTARGET (2016)
MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways
Sanjeev K. Srivastava et al.
BRITISH JOURNAL OF CANCER (2015)
MicroRNA Therapeutics: the Next Magic Bullet?
Bridget Simonson et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
Virender Kumar et al.
MOLECULAR PHARMACEUTICS (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Manuel Hidalgo et al.
PANCREATOLOGY (2015)
Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival
Yink Heay Kong et al.
PLOS ONE (2015)
Competing endogenous RNA: A novel posttranscriptional regulatory dimension associated with the progression of cancer (Review)
Qingsong Dai et al.
ONCOLOGY LETTERS (2015)
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
Makoto Abue et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
Nishant S. Gandhi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
Jakob V. Schou et al.
PLOS ONE (2014)
PRSS1 and SPINK1 mutations in idiopathic chronic and recurrent acute pancreatitis
Mario Pelaez-Luna et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition
Stephan Lindsey et al.
FRONTIERS IN ONCOLOGY (2014)
Role of microRNAs in breast cancer
Ramesh Singh et al.
CANCER BIOLOGY & THERAPY (2013)
Direct Effects of Hepatitis B Virus-Encoded Proteins and Chronic Infection in Liver Cancer Development
Marc Ringelhan et al.
DIGESTIVE DISEASES (2013)
Downregulated microRNA-200a promotes EMT and tumor growth through the Wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
Ningning Cong et al.
ONCOLOGY REPORTS (2013)
Hepatitis C Virus Core Protein Down-Regulates p21Waf1/Cip1 and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells
Tzu-Yue Shiu et al.
PLOS ONE (2013)
Reprint of: Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination
Xiaofeng Liang et al.
VACCINE (2013)
Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI
Yi-Ping Yang et al.
BIOMATERIALS (2012)
Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm
Tak-hong Cheung et al.
CELL CYCLE (2012)
ZEB2 Promotes the Metastasis of Gastric Cancer and Modulates Epithelial Mesenchymal Transition of Gastric Cancer Cells
Ying-Huan Dai et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
MicroRNA profiling: approaches and considerations
Colin C. Pritchard et al.
NATURE REVIEWS GENETICS (2012)
Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer
Tingting Wang et al.
PLOS ONE (2012)
The mechanism of selective transfection mediated by pentablock copolymers; Part II: Nuclear entry and endosomal escape
Bingqi Zhang et al.
ACTA BIOMATERIALIA (2011)
Forkhead Transcription Factor Foxq1 Promotes Epithelial-Mesenchymal Transition and Breast Cancer Metastasis
Haijun Zhang et al.
CANCER RESEARCH (2011)
MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer
Jie-Ting Tang et al.
CARCINOGENESIS (2011)
Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
Marina Y. Konopleva et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
Rochelle R. Arvizo et al.
PLOS ONE (2011)
MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis
Kohei Nakata et al.
SURGERY (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
MicroRNA Role in Thyroid Cancer Development
Francesca Marini et al.
JOURNAL OF THYROID RESEARCH (2011)
MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications
Satyanarayana Rachagani et al.
CANCER LETTERS (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Role of Mitochondria in Apoptosis
Chunxin Wang et al.
ANNUAL REVIEW OF GENETICS (2009)
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis
Kosuke Yoshihara et al.
CANCER SCIENCE (2009)
CDKN2A, NF2, and JUN Are Dysregulated Among Other Genes by miRNAs in Malignant Mesothelioma-A miRNA Microarray Analysis
Mohamed Guled et al.
GENES CHROMOSOMES & CANCER (2009)
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma
Nilva K. Cervigne et al.
HUMAN MOLECULAR GENETICS (2009)
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer
J. M. Bailey et al.
ONCOGENE (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
Jinmai Jiang et al.
CLINICAL CANCER RESEARCH (2008)
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Jennifer M. Bailey et al.
CLINICAL CANCER RESEARCH (2008)
Human Pancreatic Cancer Stem Cells: Implications for How We Treat Pancreatic Cancer
Cheong J. Lee et al.
TRANSLATIONAL ONCOLOGY (2008)
Nonviral delivery of synthetic siRNAs in vivo
Saghir Akhtar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis
Mark Bloomston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Jon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Daruka Mahadevan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
NF-kappa B links oestrogen receptor signalling and EMT
Derek C. Radisky et al.
NATURE CELL BIOLOGY (2007)
Mechanisms of cytochrome c release from mitochondria
C. Garrido et al.
CELL DEATH AND DIFFERENTIATION (2006)
Role of AIF in caspase-dependent and caspase-independent cell death
SP Cregan et al.
ONCOGENE (2004)
Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection
T Nakamura et al.
ONCOGENE (2004)
Identification of novel highly expressed genes in pancreatic ductal adenocarcinornas through a Bioinformatics analysis of expressed sequence tags
DF Cao et al.
CANCER BIOLOGY & THERAPY (2004)
分享论文
